LCO No. 224 1 of 1
General Assembly Proposed Bill No. 439
January Session, 2025
LCO No. 224
Referred to Committee on HUMAN SERVICES
Introduced by:
SEN. ANWAR, 3rd Dist.
AN ACT REQUIRING MEDICAID COVERAGE FOR BONE MARROW
AND STEM CELL TRANSPLANTS AND FDA -APPROVED GENE
THERAPIES TO TREAT SICKLE CELL DISEASE.
Be it enacted by the Senate and House of Representatives in General
Assembly convened:
That title 17b of the general statutes be amended to require the 1
Commissioner of Social Services to provide Medicaid coverage for bone 2
marrow and stem cell transplants and gene therapy approved by the 3
Food and Drug Administration to treat sickle cell disease. 4
Statement of Purpose:
To provide equitable access to life-changing medical advancements to
treat sickle cell disease, ameliorate suffering and reduce long-term
health care costs.